It selectively decreases the expression of the mRNA targets of IGF2BP1, including MYC, by limiting the association between IGF2BP1 and the coding region stability determinants of its target mRNAs, eventually suppressing the proliferation of melanomas and ovarian cancer cells 117. Here, IGF2BP1 is linked to ovarian carcinoma.